Telesis Bio Inc.

0.29
0.00 (0.00%)
At close: Mar 31, 2025, 3:45 PM
0.29
0.00%
After-hours: Apr 01, 2025, 04:00 PM EDT

Telesis Bio Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19
Net Income -47.72M -48.47M -38.96M -18.01M -8.3M
Depreciation & Amortization 4.1M 2.88M 1.57M 1.46M 857K
Stock-Based Compensation 3.96M 3.73M 1.09M 43K 13.2K
Other Working Capital -1.32M 2.98M -542K 501K 129K
Other Non-Cash Items 12.76M 1.02M 333K 706K 2.45M
Deferred Income Tax n/a n/a 2.3M 443K -486K
Change in Working Capital -7.77M 2.13M -3.04M -20K 225K
Operating Cash Flow -34.67M -38.72M -36.7M -15.38M -6.39M
Capital Expenditures -1.98M -4.47M -1.85M -204K -79K
Acquisitions n/a -556K -13.19M n/a n/a
Purchase of Investments -33.77M -77.43M n/a n/a -174.27M
Sales Maturities Of Investments 30M 64.44M n/a n/a 159.62M
Other Investing Acitivies 16K -556K n/a n/a 14.65M
Investing Cash Flow -5.74M -18.01M -15.04M -204K -79K
Debt Repayment -15.09M 4.68M 9.79M -107K n/a
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 8.25M -172K -1.19M 11K 35.11M
Financial Cash Flow 11.56M 4.51M 121.08M -96K 35.11M
Net Cash Flow -28.85M -52.21M 69.34M -15.68M -27.08M
Free Cash Flow -36.65M -43.18M -38.55M -15.59M -6.47M